Ongoing Clinical Trials Multiple Phase 3 trials are currently enrolling or analyzing data: REDEFINE program Examining cagrilintide monotherapy across diverse populations, including studies focused on long-term safety and efficacy beyond the initial 32-week trials
Topical treatment for acute phase Peyronies disease utilizing a new gel, H-100: a randomized, prospective, placebo-controlled pilot study [published correction appears in Int J Impot Res
"Losing 5% to 15% of your body weight can have significant health benefits
Glucagon-like peptide-1 736: a physiological incretin in man
Helps boost immune health Research suggests that L-theanine may help support healthy immune function
Narita K, Choudhury A, Dobrenis K, Sharma DK, Holicky EL, Marks DL, et al